Triple
T22692796
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | PTC Therapeutics |
E561093
|
entity |
| Predicate | hasDrug |
P69332
|
FINISHED |
| Object |
Emflaza
Emflaza is a corticosteroid medication (deflazacort) used primarily to treat Duchenne muscular dystrophy in patients aged two years and older.
|
E1550455
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Emflaza | Statement: [PTC Therapeutics, hasDrug, Emflaza]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Emflaza Context triple: [PTC Therapeutics, hasDrug, Emflaza]
-
A.
Falamya
Falamya is a Palestinian village located in the Qalqilya Governorate in the northwestern West Bank.
-
B.
Molazzana
Molazzana is a small municipality in Tuscany, central Italy, known for its scenic location in the Garfagnana area of the Apennine mountains.
-
C.
Faya
Faya is a town in northern Chad that serves as an important oasis and regional administrative center in the Sahara Desert.
-
D.
Fassan
Fassan is a variant name for the Ladin language spoken in the Fassa Valley of northern Italy.
-
E.
Fumusa
Fumusa is an Italian-origin surname most notably associated with American actor Dominic Fumusa.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Emflaza Triple: [PTC Therapeutics, hasDrug, Emflaza]
Generated description
Emflaza is a corticosteroid medication (deflazacort) used primarily to treat Duchenne muscular dystrophy in patients aged two years and older.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Emflaza Target entity description: Emflaza is a corticosteroid medication (deflazacort) used primarily to treat Duchenne muscular dystrophy in patients aged two years and older.
-
A.
Falamya
Falamya is a Palestinian village located in the Qalqilya Governorate in the northwestern West Bank.
-
B.
Molazzana
Molazzana is a small municipality in Tuscany, central Italy, known for its scenic location in the Garfagnana area of the Apennine mountains.
-
C.
Faya
Faya is a town in northern Chad that serves as an important oasis and regional administrative center in the Sahara Desert.
-
D.
Fassan
Fassan is a variant name for the Ladin language spoken in the Fassa Valley of northern Italy.
-
E.
Fumusa
Fumusa is an Italian-origin surname most notably associated with American actor Dominic Fumusa.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789ba0148190891781d05ec64f3c |
completed | April 29, 2026, 3:18 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a0b7eccc1408190a9d2473700154bd3 |
completed | May 18, 2026, 9:04 p.m. |
| NEDg | Description generation | batch_6a0b7fd717b88190875264662193a43a |
completed | May 18, 2026, 9:08 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0b807b4f748190bf4172469502c150 |
completed | May 18, 2026, 9:11 p.m. |
Created at: April 17, 2026, 3:13 p.m.